 |
 |
 |
|
 | |||||
| |||||||||
 | |||||||||
|
|
 |
|
|
Prescription and Over-the-Counter Drug Product List Prescription OTCNOTE: The format for the Monthly Additions/Deletions Drug
Product List changed as of the July Cumulative Supplement (CS) of the 21st
Edition to mirror the CS. Refer to the CS Preface section 1.6
Cumulative Supplement Legend. ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST ACETAMINOPHEN; HYDROCODONE BITARTRATE
TABLET; ORAL
HYDROCODONE BITARTRATE AND ACETAMINOPHEN
>D> AA UCB INC 500MG;10MG N40210 001 Aug 13, 1997 May DISC
>A> @ 500MG;10MG N40210 001 Aug 13, 1997 May DISC
>D> AA 650MG;7.5MG N40134 001 Nov 21, 1996 May DISC
>A> @ 650MG;7.5MG N40134 001 Nov 21, 1996 May DISC
ACETAZOLAMIDE
CAPSULE, EXTENDED RELEASE; ORAL
DIAMOX
>D> @ DURAMED PHARMS 500MG N12945 001 May CMFD
>A> + 500MG N12945 001 May CMFD
ALBUTEROL SULFATE
SOLUTION; INHALATION
ALBUTEROL SULFATE
>D> AN ROXANE EQ 0.083% BASE N75129 001 Feb 13, 2001 May DISC
>A> @ EQ 0.083% BASE N75129 001 Feb 13, 2001 May DISC
ALLOPURINOL SODIUM
INJECTABLE; INJECTION
ALOPRIM
>A> AP + BIONICHE PHARMA EQ 500MG BASE/VIAL N20298 001 May 17, 1996 May CAHN
>D> AP + NABI EQ 500MG BASE/VIAL N20298 001 May 17, 1996 May CAHN
ALPRAZOLAM
TABLET, EXTENDED RELEASE; ORAL
ALPRAZOLAM
>A> AB IMPAX LABS 0.5MG N77968 004 May 24, 2007 May NEWA
>A> AB 1MG N77968 003 May 24, 2007 May NEWA
>A> AB 2MG N77968 002 May 24, 2007 May NEWA
>A> AB 3MG N77968 001 May 24, 2007 May NEWA
AMIODARONE HYDROCHLORIDE
INJECTABLE; INJECTION
>D> CORDARONE
>D> AP + WYETH PHARMS 50MG/ML N20377 001 Aug 03, 1995 May DISC
>A> @ 50MG/ML N20377 001 Aug 03, 1995 May DISC
AMLODIPINE BESYLATE
TABLET; ORAL
AMLODIPINE BESYLATE
>A> AB APOTEX EQ 2.5MG BASE N76719 001 May 23, 2007 May NEWA
>A> AB EQ 5MG BASE N76719 002 May 23, 2007 May NEWA
>A> AB EQ 10MG BASE N76719 003 May 23, 2007 May NEWA
AMLODIPINE BESYLATE; BENAZEPRIL HYDROCHLORIDE
CAPSULE; ORAL
>A> AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE
>A> AB TEVA PHARMS EQ 2.5MG BASE;10MG N77179 001 May 18, 2007 May NEWA
>A> AB EQ 5MG BASE;10MG N77179 002 May 18, 2007 May NEWA
>A> AB EQ 5MG BASE;20MG N77179 003 May 18, 2007 May NEWA
>A> AB EQ 10MG BASE;20MG N77179 004 May 18, 2007 May NEWA
LOTREL
>D> NOVARTIS EQ 2.5MG BASE;10MG N20364 002 Mar 03, 1995 May CFTG
>A> AB EQ 2.5MG BASE;10MG N20364 002 Mar 03, 1995 May CFTG
>D> EQ 5MG BASE;10MG N20364 003 Mar 03, 1995 May CFTG
>A> AB EQ 5MG BASE;10MG N20364 003 Mar 03, 1995 May CFTG
>D> EQ 5MG BASE;20MG N20364 004 Mar 03, 1995 May CFTG
>A> AB EQ 5MG BASE;20MG N20364 004 Mar 03, 1995 May CFTG
>D> EQ 10MG BASE;20MG N20364 005 Jun 20, 2002 May CFTG
>A> AB EQ 10MG BASE;20MG N20364 005 Jun 20, 2002 May CFTG
AMOXICILLIN
CAPSULE; ORAL
>D> TRIMOX
>D> AB APOTHECON 250MG N61885 001 May DISC
>A> @ 250MG N61885 001 May DISC
>D> AB 500MG N61885 002 May DISC
>A> @ 500MG N61885 002 May DISC
AZACITIDINE
>A> INJECTABLE; IV-SC
>A> VIDAZA
>A> + PHARMION 100MG/VIAL N50794 001 May 19, 2004 May CDFR
>D> INJECTABLE; SUBCUTANEOUS
>D> VIDAZA
>D> + PHARMION 100MG/VIAL N50794 001 May 19, 2004 May CDFR
AZITHROMYCIN
INJECTABLE; INJECTION
AZITHROMYCIN
>D> AP + SICOR PHARMS EQ 500MG BASE/VIAL N50809 001 Dec 19, 2006 May CAHN
>D> + EQ 2.5GM BASE/VIAL N50809 002 Dec 19, 2006 May CAHN
>A> AP + TEVA PARENTERAL EQ 500MG BASE/VIAL N50809 001 Dec 19, 2006 May CAHN
>A> + EQ 2.5GM BASE/VIAL N50809 002 Dec 19, 2006 May CAHN
SOLUTION/DROPS; OPHTHALMIC
AZASITE
>D> + INSITE VISION 1% N50810 001 Apr 27, 2007 May CAHN
>A> + INSPIRE 1% N50810 001 Apr 27, 2007 May CAHN
TABLET; ORAL
AZITHROMYCIN
>A> AB MYLAN EQ 250MG BASE N65365 001 May 30, 2007 May NEWA
>A> AB EQ 500MG BASE N65366 001 May 30, 2007 May NEWA
BETAMETHASONE DIPROPIONATE
LOTION, AUGMENTED; TOPICAL
>A> BETAMETHASONE DIPROPIONATE
>A> AB ALTANA EQ 0.05% BASE N77111 001 May 21, 2007 May NEWA
>A> AB TARO EQ 0.05% BASE N77477 001 May 21, 2007 May NEWA
DIPROLENE
>D> + SCHERING EQ 0.05% BASE N19716 001 Aug 01, 1988 May CFTG
>A> AB + EQ 0.05% BASE N19716 001 Aug 01, 1988 May CFTG
>D> BISKALCITRATE; METRONIDAZOLE; TETRACYCLINE
>D> CAPSULE; ORAL
>D> PYLERA
>D> + AXCAN 140MG;125MG;125MG N50786 001 Sep 28, 2006 May CAIN
>A> BISMUTH SUBCITRATE POTASSIUM; METRONIDAZOLE; TETRACYCLINE
>A> CAPSULE; ORAL
>A> PYLERA
>A> + AXCAN 140MG;125MG;125MG N50786 001 Sep 28, 2006 May CAIN
BUPIVACAINE HYDROCHLORIDE
INJECTABLE; INJECTION
SENSORCAINE
>A> AP ABRAXIS 0.25% N70552 001 May 21, 1986 May CAHN
>A> AP 0.25% N18304 001 May CAHN
>A> AP 0.5% N70553 001 May 21, 1986 May CAHN
>A> AP 0.5% N18304 002 May CAHN
>A> AP 0.75% N70554 001 May 21, 1986 May CAHN
>A> AP 0.75% N18304 003 May CAHN
>D> AP ASTRAZENECA 0.25% N70552 001 May 21, 1986 May CAHN
>D> AP 0.25% N18304 001 May CAHN
>D> AP 0.5% N70553 001 May 21, 1986 May CAHN
>D> AP 0.5% N18304 002 May CAHN
>D> AP 0.75% N70554 001 May 21, 1986 May CAHN
>D> AP 0.75% N18304 003 May CAHN
INJECTABLE; SPINAL
SENSORCAINE
>A> AP ABRAXIS 0.75% N71202 001 Apr 15, 1987 May CAHN
>D> AP ASTRAZENECA 0.75% N71202 001 Apr 15, 1987 May CAHN
BUPIVACAINE HYDROCHLORIDE; EPINEPHRINE BITARTRATE
INJECTABLE; INJECTION
SENSORCAINE
>A> AP ABRAXIS 0.25%;0.0091MG/ML N70967 001 Oct 13, 1987 May CAHN
>A> AP 0.25%;0.0091MG/ML N70966 001 Oct 13, 1987 May CAHN
>A> AP 0.5%;0.0091MG/ML N70968 001 Oct 13, 1987 May CAHN
>A> AP 0.5%;0.0091MG/ML N18304 004 Sep 02, 1983 May CAHN
>A> AP 0.75%;0.0091MG/ML N18304 005 Sep 02, 1983 May CAHN
>D> AP ASTRAZENECA 0.25%;0.0091MG/ML N70967 001 Oct 13, 1987 May CAHN
>D> AP 0.25%;0.0091MG/ML N70966 001 Oct 13, 1987 May CAHN
>D> AP 0.5%;0.0091MG/ML N70968 001 Oct 13, 1987 May CAHN
>D> AP 0.5%;0.0091MG/ML N18304 004 Sep 02, 1983 May CAHN
>D> AP 0.75%;0.0091MG/ML N18304 005 Sep 02, 1983 May CAHN
CAFFEINE CITRATE
SOLUTION; INTRAVENOUS
CAFFEINE CITRATE
>A> AP LUITPOLD EQ 30MG BASE/3ML (EQ 10MG N77906 001 May 15, 2007 May NEWA
CEFACLOR
CAPSULE; ORAL
CEFACLOR
>D> AB TEVA EQ 250MG BASE N64145 001 Jun 24, 1996 May DISC
>A> @ EQ 250MG BASE N64145 001 Jun 24, 1996 May DISC
>D> AB EQ 500MG BASE N64145 002 Jun 24, 1996 May DISC
>A> @ EQ 500MG BASE N64145 002 Jun 24, 1996 May DISC
CEFADROXIL/CEFADROXIL HEMIHYDRATE
CAPSULE; ORAL
CEFADROXIL
>D> AB AUROBINDO 500MG N65352 001 Jan 25, 2007 May CPOT
>A> AB EQ 500MG BASE N65352 001 Jan 25, 2007 May CPOT
>A> AB LUPIN EQ 500MG BASE N65392 001 May 29, 2007 May NEWA
CEFAZOLIN SODIUM
INJECTABLE; INJECTION
CEFAZOLIN SODIUM
>A> AP SANDOZ EQ 1GM BASE/VIAL N65345 001 May 09, 2007 May NEWA
CEFDINIR
CAPSULE; ORAL
CEFDINIR
>A> AB TEVA PHARMS 300MG N65368 001 May 09, 2007 May NEWA
CEFPROZIL
TABLET; ORAL
CEFPROZIL
>A> AB AUROBINDO 250MG N65340 001 May 24, 2007 May NEWA
>A> AB 500MG N65340 002 May 24, 2007 May NEWA
CEPHALEXIN
FOR SUSPENSION; ORAL
CEPHALEXIN
>D> + CEPH INTL EQ 100MG BASE/ML N62117 001 May DISC
>A> @ EQ 100MG BASE/ML N62117 001 May DISC
>D> AB TEVA EQ 125MG BASE/5ML N62767 001 Jun 16, 1987 May DISC
>A> @ EQ 125MG BASE/5ML N62767 001 Jun 16, 1987 May DISC
>D> AB EQ 250MG BASE/5ML N62768 001 Jun 16, 1987 May DISC
>A> @ EQ 250MG BASE/5ML N62768 001 Jun 16, 1987 May DISC
>D> CEPHRADINE
>D> CAPSULE; ORAL
>D> CEPHRADINE
>D> TEVA 250MG N62683 001 Jan 09, 1987 May DISC
>A> @ 250MG N62683 001 Jan 09, 1987 May DISC
>D> + 500MG N62683 002 Jan 09, 1987 May DISC
>A> @ 500MG N62683 002 Jan 09, 1987 May DISC
>D> FOR SUSPENSION; ORAL
>D> ANSPOR
>D> AB GLAXOSMITHKLINE 125MG/5ML N61866 001 May DISC
>A> @ 125MG/5ML N61866 001 May DISC
>D> AB 250MG/5ML N61866 002 May DISC
>A> @ 250MG/5ML N61866 002 May DISC
>D> CEPHRADINE
>D> AB TEVA 125MG/5ML N62693 001 Jan 09, 1987 May DISC
>A> @ 125MG/5ML N62693 001 Jan 09, 1987 May DISC
>D> AB 250MG/5ML N62693 002 Jan 09, 1987 May DISC
>A> @ 250MG/5ML N62693 002 Jan 09, 1987 May DISC
>D> VELOSEF '125'
>D> AB + APOTHECON 125MG/5ML N61763 001 May DISC
>A> @ 125MG/5ML N61763 001 May DISC
>D> VELOSEF '250'
>D> AB + APOTHECON 250MG/5ML N61763 002 May DISC
>A> @ 250MG/5ML N61763 002 May DISC
CITALOPRAM HYDROBROMIDE
TABLET; ORAL
CITALOPRAM HYDROBROMIDE
>D> AB ROXANE EQ 10MG BASE N77041 001 Nov 23, 2004 May DISC
>A> @ EQ 10MG BASE N77041 001 Nov 23, 2004 May DISC
>D> AB EQ 20MG BASE N77041 002 Nov 23, 2004 May DISC
>A> @ EQ 20MG BASE N77041 002 Nov 23, 2004 May DISC
CLINDAMYCIN PHOSPHATE
INJECTABLE; INJECTION
CLINDAMYCIN PHOSPHATE
>A> AP ABRAXIS PHARM EQ 150MG BASE/ML N65347 001 May 09, 2007 May NEWA
CLOCORTOLONE PIVALATE
CREAM; TOPICAL
CLODERM
>A> + CORIA 0.1% N17765 001 May CAHN
>D> + HEALTHPOINT 0.1% N17765 001 May CAHN
CLOZAPINE
TABLET, ORALLY DISINTEGRATING; ORAL
FAZACLO ODT
>A> AVANIR PHARMS 12.5MG N21590 004 May 30, 2007 May NEWA
CROMOLYN SODIUM
SOLUTION; INHALATION
CROMOLYN SODIUM
>D> AN ROXANE 10MG/ML N75175 001 Sep 30, 1999 May DISC
>A> @ 10MG/ML N75175 001 Sep 30, 1999 May DISC
DALTEPARIN SODIUM
>D> INJECTABLE; INJECTION
>D> FRAGMIN
>D> + PHARMACIA AND 2,500 IU/0.2ML N20287 001 Dec 22, 1994 May CDFR
>D> + 5,000 IU/0.2ML N20287 003 Mar 18, 1996 May CDFR
>D> + 7,500 IU/0.3ML N20287 005 Apr 04, 2002 May CDFR
>D> + 10,000 IU/ML N20287 004 Jan 30, 1998 May CDFR
>D> + 95,000IU/3.8ML(25,000IU/ML) N20287 006 Apr 04, 2002 May CDFR
>D> + 95,000IU/9.5ML(10,000IU/ML) N20287 007 Apr 04, 2002 May CDFR
>A> INJECTABLE; SUBCUTANEOUS
>A> FRAGMIN
>A> + PHARMACIA AND 2,500IU/0.2ML (12,500IU/ML) N20287 001 Dec 22, 1994 May CDFR
>A> + 5,000IU/0.2ML (25,000IU/ML) N20287 003 Mar 18, 1996 May CDFR
>A> + 7,500IU/0.3ML (25,000IU/ML) N20287 005 Apr 04, 2002 May CDFR
>A> + 10,000IU/0.4ML (25,000IU/ML) N20287 002 May 01, 2007 May NEWA
>A> + 10,000IU/ML (10,000IU/ML) N20287 004 Jan 30, 1998 May CDFR
>A> + 12,500IU/0.5ML (25,000IU/ML) N20287 009 May 01, 2007 May NEWA
>A> + 15,000IU/0.6ML (25,000IU/ML) N20287 010 May 01, 2007 May NEWA
>A> + 18,000IU/0.72ML (25,000IU/ML) N20287 011 May 01, 2007 May NEWA
>A> + 95,000IU/3.8ML(25,000IU/ML) N20287 006 Apr 04, 2002 May CDFR
>A> + 95,000IU/9.5ML(10,000IU/ML) N20287 007 Apr 04, 2002 May CDFR
DAPSONE
GEL; TOPICAL
ACZONE
>A> @ QLT USA 5% N21794 001 Jul 07, 2005 May CAHN
>D> @ TOLMAR 5% N21794 001 Jul 07, 2005 May CAHN
DEFEROXAMINE MESYLATE
INJECTABLE; INJECTION
DEFEROXAMINE MESYLATE
>A> AP BEDFORD 500MG/VIAL N78086 001 May 30, 2007 May NEWA
>A> AP 2GM/VIAL N78086 002 May 30, 2007 May NEWA
DESONIDE
CREAM; TOPICAL
>A> DESONIDE
>A> AB + PERRIGO NEW YORK 0.05% N17010 001 May CTNA
>D> TRIDESILON
>D> AB + PERRIGO NEW YORK 0.05% N17010 001 May CTNA
OINTMENT; TOPICAL
>A> DESONIDE
>A> AB + PERRIGO NEW YORK 0.05% N17426 001 May CTNA
>D> TRIDESILON
>D> AB + PERRIGO NEW YORK 0.05% N17426 001 May CTNA
DIAZOXIDE
SUSPENSION; ORAL
PROGLYCEM
>D> + BAKER NORTON 50MG/ML N17453 001 May CAHN
>A> + IVAX RES 50MG/ML N17453 001 May CAHN
DIFLORASONE DIACETATE
OINTMENT; TOPICAL
>D> FLORONE
>D> @ PHARMACIA AND 0.05% N17994 001 May CTNA
>A> PSORCON E
>A> @ PHARMACIA AND 0.05% N17994 001 May CTNA
ECONAZOLE NITRATE
CREAM; TOPICAL
ECONAZOLE NITRATE
>D> AB HEALTHPOINT 1% N76574 001 Dec 17, 2004 May CAHN
>A> AB PRASCO 1% N76574 001 Dec 17, 2004 May CAHN
ENALAPRILAT
INJECTABLE; INJECTION
VASOTEC
>D> @ BIOVAIL LABS INTL 1.25MG/ML N19309 001 Feb 09, 1988 May CMFD
>A> AP + 1.25MG/ML N19309 001 Feb 09, 1988 May CMFD
ERYTHROMYCIN
OINTMENT; TOPICAL
AKNE-MYCIN
>A> + CORIA 2% N50584 001 Jan 10, 1985 May CAHN
>D> + HEALTHPOINT 2% N50584 001 Jan 10, 1985 May CAHN
SWAB; TOPICAL
>D> C-SOLVE-2
>D> AT IVAX PHARMS 2% N62751 001 Jul 30, 1993 May DISC
>A> @ 2% N62751 001 Jul 30, 1993 May DISC
>D> ERYCETTE
>D> AT + J AND J 2% N50594 001 Feb 15, 1985 May DISC
>A> @ 2% N50594 001 Feb 15, 1985 May DISC
ERYTHROMYCIN
>D> AT ALTANA 2% N65320 001 Jul 25, 2006 May CRLD
>A> AT + 2% N65320 001 Jul 25, 2006 May CRLD
>D> AT STIEFEL 2% N64128 001 Jul 03, 1996 May DISC
>A> @ 2% N64128 001 Jul 03, 1996 May DISC
>D> AT 2% N64126 001 Jul 03, 1996 May CRLD
>A> AT + 2% N64126 001 Jul 03, 1996 May CRLD
ESTAZOLAM
TABLET; ORAL
ESTAZOLAM
>D> AB TEVA 2MG N74921 002 Jul 10, 1997 May CRLD
>A> AB + 2MG N74921 002 Jul 10, 1997 May CRLD
ETHINYL ESTRADIOL; LEVONORGESTREL
TABLET; ORAL
>A> LYBREL
>A> + WYETH PHARMS 0.02MG;0.09MG N21864 001 May 22, 2007 May NEWA
FLUOXETINE HYDROCHLORIDE
CAPSULE; ORAL
FLUOXETINE
>A> AB MYLAN EQ 40MG BASE N75207 003 May 25, 2007 May NEWA
>A> FORMOTEROL FUMARATE
>A> SOLUTION; INHALATION
>A> PERFOROMIST
>A> + DEY LP 0.02MG/2ML N22007 001 May 11, 2007 May NEWA
GABAPENTIN
CAPSULE; ORAL
GABAPENTIN
>A> AB WATSON LABS 100MG N75485 003 May 11, 2007 May NEWA
>A> AB 300MG N75485 002 May 11, 2007 May NEWA
>A> AB 400MG N75485 001 May 11, 2007 May NEWA
GEMFIBROZIL
TABLET; ORAL
GEMFIBROZIL
>A> AB IMPAX PHARMS 600MG N78207 001 Jun 01, 2007 May NEWA
HISTRELIN ACETATE
IMPLANT; SUBCUTANEOUS
>A> SUPPRELIN LA
>A> + INDEVUS 50MG N22058 001 May 03, 2007 May NEWA
HYDROCORTISONE BUTYRATE
>A> LOTION; TOPICAL
>A> LOCOID
>A> + FERNDALE LABS 0.1% N22076 001 May 18, 2007 May NEWA
IDARUBICIN HYDROCHLORIDE
INJECTABLE; INJECTION
IDARUBICIN HYDROCHLORIDE
>A> AP BEDFORD LABS 1MG/ML N65288 001 May 15, 2007 May NEWA
INDIUM IN-111 CHLORIDE
INJECTABLE; INJECTION
INDICLOR
>D> + AMERSHAM 2mCi/0.2ML N19862 001 Dec 29, 1992 May CAHN
>A> + GE HEALTHCARE 2mCi/0.2ML N19862 001 Dec 29, 1992 May CAHN
INSULIN GLULISINE RECOMBINANT
>A> INJECTABLE; IV (INFUSION)-SC
>A> APIDRA
>A> + SANOFI AVENTIS US 1000 UNITS/10ML (100 UNITS/ML) N21629 001 Apr 16, 2004 May CDFR
>A> + 300 UNITS/3ML (100 UNITS/ML) N21629 002 Dec 20, 2005 May CDFR
>D> INJECTABLE; SUBCUTANEOUS
>D> APIDRA
>D> + SANOFI AVENTIS US 1000 UNITS/10ML (100 UNITS/ML) N21629 001 Apr 16, 2004 May CDFR
>D> + 300 UNITS/3ML (100 UNITS/ML) N21629 002 Dec 20, 2005 May CDFR
LEUCOVORIN CALCIUM
INJECTABLE; INJECTION
LEUCOVORIN CALCIUM
>D> AP PHARMACHEMIE EQ 350MG BASE/VIAL N40262 001 Dec 15, 1999 May DISC
>A> @ EQ 350MG BASE/VIAL N40262 001 Dec 15, 1999 May DISC
>D> AP PHARMACHEMIE USA EQ 50MG BASE/VIAL N89628 001 Apr 17, 1997 May DISC
>A> @ EQ 50MG BASE/VIAL N89628 001 Apr 17, 1997 May DISC
>A> LEVOCETIRIZINE DIHYDROCHLORIDE
>A> TABLET; ORAL
>A> XYZAL
>A> + UCB INC 5MG N22064 001 May 25, 2007 May NEWA
LISDEXAMFETAMINE DIMESYLATE
CAPSULE; ORAL
VYVANSE
>D> NEW RIVER 30MG N21977 001 Feb 23, 2007 May CAHN
>D> 50MG N21977 002 Feb 23, 2007 May CAHN
>D> + 70MG N21977 003 Feb 23, 2007 May CAHN
>A> NEW RIVER 30MG N21977 001 Feb 23, 2007 May CAHN
>A> 50MG N21977 002 Feb 23, 2007 May CAHN
>A> + 70MG N21977 003 Feb 23, 2007 May CAHN
MAFENIDE ACETATE
CREAM; TOPICAL
SULFAMYLON
>D> + MYLAN BERTEK EQ 85MG BASE/GM N16763 001 May CAHN
>A> + UDL LABS EQ 85MG BASE/GM N16763 001 May CAHN
FOR SOLUTION; TOPICAL
SULFAMYLON
>D> + MYLAN BERTEK 5% N19832 003 Jun 05, 1998 May CAHN
>A> + UDL LABS 5% N19832 003 Jun 05, 1998 May CAHN
MEPIVACAINE HYDROCHLORIDE
INJECTABLE; INJECTION
POLOCAINE
>A> AP ABRAXIS 1% N89407 001 Dec 01, 1986 May CAHN
>A> AP 2% N89410 001 Dec 01, 1986 May CAHN
>D> AP ASTRAZENECA 1% N89407 001 Dec 01, 1986 May CAHN
>D> AP 2% N89410 001 Dec 01, 1986 May CAHN
POLOCAINE-MPF
>A> AP ABRAXIS 1% N89406 001 Dec 01, 1986 May CAHN
>A> AP 1.5% N89408 001 Dec 01, 1986 May CAHN
>A> AP 2% N89409 001 Dec 01, 1986 May CAHN
>D> AP ASTRAZENECA 1% N89406 001 Dec 01, 1986 May CAHN
>D> AP 1.5% N89408 001 Dec 01, 1986 May CAHN
>D> AP 2% N89409 001 Dec 01, 1986 May CAHN
>A> MERCAPTOPURINE
>A> TABLET; ORAL
>A> MERCAPTOPURINE
>A> AB MYLAN 50MG N40594 001 Jul 01, 2005 May CAIN
>D> MERCAPTOPURINE ANHYDROUS
>D> TABLET; ORAL
>D> MERCAPTOPURINE
>D> AB MYLAN 50MG N40594 001 Jul 01, 2005 May CAIN
>A> METFORMIN HYDROCHLORIDE; PIOGLITAZONE HYDROCHLORIDE
>A> TABLET; ORAL
>A> ACTOPLUS MET
>A> TAKEDA GLOBAL 500MG;EQ 15MG BASE N21842 001 Aug 29, 2005 May CAIN
>A> + 850MG;EQ 15MG BASE N21842 002 Aug 29, 2005 May CAIN
>D> METFORMIN; PIOGLITAZONE HYDROCHLORIDE
>D> TABLET; ORAL
>D> ACTOPLUS MET
>D> TAKEDA GLOBAL 500MG;EQ 15MG BASE N21842 001 Aug 29, 2005 May CAIN
>D> + 850MG;EQ 15MG BASE N21842 002 Aug 29, 2005 May CAIN
METHADONE HYDROCHLORIDE
TABLET; ORAL
METHADONE HYDROCHLORIDE
>D> AA ROXANE 5MG N88108 001 Mar 08, 1983 May DISC
>A> @ 5MG N88108 001 Mar 08, 1983 May DISC
>D> AA 10MG N88109 001 Mar 08, 1983 May DISC
>A> @ 10MG N88109 001 Mar 08, 1983 May DISC
>D> AA 40MG N74081 001 Apr 28, 1995 May DISC
>A> @ 40MG N74081 001 Apr 28, 1995 May DISC
METHYLPHENIDATE HYDROCHLORIDE
CAPSULE, EXTENDED RELEASE; ORAL
METADATE CD
>D> BX + UCB INC 30MG N21259 002 Jun 19, 2003 May CRLD
>A> BX 30MG N21259 002 Jun 19, 2003 May CRLD
METOLAZONE
TABLET; ORAL
METOLAZONE
>D> AB ROXANE 10MG N76482 002 Apr 29, 2004 May DISC
>A> @ 10MG N76482 002 Apr 29, 2004 May DISC
METOPROLOL SUCCINATE
TABLET, EXTENDED RELEASE; ORAL
METOPROLOL SUCCINATE
>A> AB KV PHARM EQ 100MG TARTRATE N76640 002 May 18, 2007 May NEWA
>A> AB EQ 200MG TARTRATE N76640 001 May 18, 2007 May NEWA
>A> AB SANDOZ EQ 50MG TARTRATE N76969 002 May 18, 2007 May NEWA
TOPROL-XL
>D> + ASTRAZENECA EQ 50MG TARTRATE N19962 001 Jan 10, 1992 May CFTG
>A> AB + EQ 50MG TARTRATE N19962 001 Jan 10, 1992 May CFTG
>D> EQ 100MG TARTRATE N19962 002 Jan 10, 1992 May CFTG
>A> AB EQ 100MG TARTRATE N19962 002 Jan 10, 1992 May CFTG
>D> + EQ 200MG TARTRATE N19962 003 Jan 10, 1992 May CFTG
>A> AB + EQ 200MG TARTRATE N19962 003 Jan 10, 1992 May CFTG
METOPROLOL TARTRATE
INJECTABLE; INJECTION
METOPROLOL TARTRATE
>A> AP HIKMA 1MG/ML N77761 001 May 30, 2007 May NEWA
MORPHINE SULFATE
INJECTABLE; INJECTION
ASTRAMORPH PF
>A> AP ABRAXIS 0.5MG/ML N71051 001 Oct 07, 1986 May CAHN
>A> AP 0.5MG/ML N71050 001 Oct 07, 1986 May CAHN
>A> AP 1MG/ML N71053 001 Oct 07, 1986 May CAHN
>A> AP 1MG/ML N71052 001 Oct 07, 1986 May CAHN
>D> AP ASTRAZENECA 0.5MG/ML N71051 001 Oct 07, 1986 May CAHN
>D> AP 0.5MG/ML N71050 001 Oct 07, 1986 May CAHN
>D> AP 1MG/ML N71053 001 Oct 07, 1986 May CAHN
>D> AP 1MG/ML N71052 001 Oct 07, 1986 May CAHN
OXYBUTYNIN CHLORIDE
TABLET, EXTENDED RELEASE; ORAL
OXYBUTYNIN CHLORIDE
>A> AB IMPAX PHARMS 5MG N76745 002 May 09, 2007 May NEWA
>A> AB 10MG N76745 003 May 09, 2007 May NEWA
>A> AB MYLAN 15MG N78293 001 May 10, 2007 May NEWA
OXYCODONE HYDROCHLORIDE
TABLET, EXTENDED RELEASE; ORAL
OXYCONTIN
>D> PURDUE PHARMA LP 15MG N20553 006 Sep 18, 2006 May DISC
>A> @ 15MG N20553 006 Sep 18, 2006 May DISC
>D> 30MG N20553 007 Sep 18, 2006 May DISC
>A> @ 30MG N20553 007 Sep 18, 2006 May DISC
>D> 60MG N20553 008 Sep 18, 2006 May DISC
>A> @ 60MG N20553 008 Sep 18, 2006 May DISC
POLYETHYLENE GLYCOL 3350
FOR SOLUTION; ORAL
POLYETHYLENE GLYCOL 3350
>D> AA COASTAL PHARMS 17GM/SCOOPFUL N77893 001 May 26, 2006 May CAHN
>A> AA PADDOCK 17GM/SCOOPFUL N77893 001 May 26, 2006 May CAHN
POLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM
FOR SUSPENSION; ORAL
GO-EVAC
>A> AA BOCA PHARMA 236GM/BOT;2.97GM/BOT;6.74GM/BOT; N73433 001 Apr 28, 1992 May CAHN
>D> AA COPLEY PHARM 236GM/BOT;2.97GM/BOT;6.74GM/BOT; N73433 001 Apr 28, 1992 May CAHN
PRAVASTATIN SODIUM
TABLET; ORAL
PRAVASTATIN SODIUM
>A> AB GLENMARK 10MG N77987 001 May 11, 2007 May NEWA
>A> AB 20MG N77987 002 May 11, 2007 May NEWA
>A> AB 40MG N77987 003 May 11, 2007 May NEWA
PROPRANOLOL HYDROCHLORIDE
>D> CONCENTRATE; ORAL
>D> PROPRANOLOL HYDROCHLORIDE INTENSOL
>D> + ROXANE 80MG/ML N71388 001 May 15, 1987 May DISC
>A> @ 80MG/ML N71388 001 May 15, 1987 May DISC
QUETIAPINE FUMARATE
>A> TABLET, EXTENDED RELEASE; ORAL
>A> SEROQUEL XR
>A> ASTRAZENECA 50MG N22047 001 May 17, 2007 May NEWA
>A> 200MG N22047 002 May 17, 2007 May NEWA
>A> 300MG N22047 003 May 17, 2007 May NEWA
>A> + 400MG N22047 004 May 17, 2007 May NEWA
>A> ROTIGOTINE
>A> FILM, EXTENDED RELEASE; TRANSDERMAL
>A> NEUPRO
>A> SCHWARZ 2MG/24HR N21829 001 May 09, 2007 May NEWA
>A> 4MG/24HR N21829 002 May 09, 2007 May NEWA
>A> + 6MG/24HR N21829 003 May 09, 2007 May NEWA
SIMVASTATIN
TABLET; ORAL
SIMVASTATIN
>A> AB LUPIN 10MG N78103 001 May 11, 2007 May NEWA
>A> AB 20MG N78103 002 May 11, 2007 May NEWA
>A> AB 40MG N78103 003 May 11, 2007 May NEWA
>A> AB 80MG N78103 004 May 11, 2007 May NEWA
TAMOXIFEN CITRATE
TABLET; ORAL
TAMOXIFEN CITRATE
>D> AB PHARMACHEMIE EQ 20MG BASE N74858 001 Feb 20, 2003 May CRLD
>A> AB + TEVA PHARMS EQ 20MG BASE N74858 001 Feb 20, 2003 May CRLD
TECHNETIUM TC-99M SESTAMIBI KIT
INJECTABLE; INJECTION
>D> MIRALUMA
>D> + BRISTOL MYERS N/A N19785 003 May 23, 1997 May DISC
>A> @ N/A N19785 003 May 23, 1997 May DISC
>A> TEMSIROLIMUS
>A> SOLUTION; INTRAVENOUS
>A> TORISEL
>A> + WYETH PHARMS 25MG/ML (25MG/ML) N22088 001 May 30, 2007 May NEWA
TESTOSTERONE
GEL; TRANSDERMAL
TESTOSTERONE
>A> AB PAR PHARM 1% N76744 001 May 23, 2007 May NEWA
TETRACYCLINE HYDROCHLORIDE
FIBER, EXTENDED RELEASE; PERIODONTAL
ACTISITE
>D> @ ALZA 12.7MG/FIBER N50653 001 Mar 25, 1994 May CAHN
>A> @ ON SITE 12.7MG/FIBER N50653 001 Mar 25, 1994 May CAHN
THIORIDAZINE HYDROCHLORIDE
CONCENTRATE; ORAL
>D> THIORIDAZINE HYDROCHLORIDE INTENSOL
>D> AA ROXANE 30MG/ML N88941 001 Dec 16, 1985 May DISC
>A> @ 30MG/ML N88941 001 Dec 16, 1985 May DISC
>D> AA 100MG/ML N88942 001 Dec 16, 1985 May DISC
>A> @ 100MG/ML N88942 001 Dec 16, 1985 May DISC
TRANDOLAPRIL; VERAPAMIL HYDROCHLORIDE
TABLET, EXTENDED RELEASE; ORAL
TARKA
>D> + ABBOTT 1MG;240MG N20591 003 Oct 22, 1996 May CRLD
>A> 1MG;240MG N20591 003 Oct 22, 1996 May CRLD
>D> + 2MG;180MG N20591 001 Oct 22, 1996 May CRLD
>A> 2MG;180MG N20591 001 Oct 22, 1996 May CRLD
>D> + 2MG;240MG N20591 004 Oct 22, 1996 May CRLD
>A> 2MG;240MG N20591 004 Oct 22, 1996 May CRLD
VERAPAMIL HYDROCHLORIDE
CAPSULE, EXTENDED RELEASE; ORAL
VERELAN
>D> AB + ELAN DRUG 120MG N19614 001 May 29, 1990 May CRLD
>A> AB 120MG N19614 001 May 29, 1990 May CRLD
>D> AB + 180MG N19614 003 Jan 09, 1992 May CRLD
>A> AB 180MG N19614 003 Jan 09, 1992 May CRLD
>D> AB + 240MG N19614 002 May 29, 1990 May CRLD
>A> AB 240MG N19614 002 May 29, 1990 May CRLD
ZICONOTIDE
INJECTABLE; INTRATHECAL
PRIALT
>D> + ELAN PHARMS 100UGM/1ML(100MG/ML) N21060 002 Dec 28, 2004 May CPOT
>A> + 100UGM/1ML(100UGM/ML) N21060 002 Dec 28, 2004 May CPOT
>D> + 500UGM/20ML(25MG/ML) N21060 001 Dec 28, 2004 May CPOT
>A> + 500UGM/20ML(25UGM/ML) N21060 001 Dec 28, 2004 May CPOT
>D> + 500UGM/5ML(100MG/ML) N21060 004 Dec 28, 2004 May CPOT
>A> + 500UGM/5ML(100UGM/ML) N21060 004 Dec 28, 2004 May CPOT
ZIDOVUDINE
CAPSULE; ORAL
ZIDOVUDINE
>A> AB CIPLA LTD 100MG N78349 001 May 23, 2007 May NEWA
ZILEUTON
>A> TABLET, EXTENDED RELEASE; ORAL
>A> ZYFLO CR
>A> + CRITICAL 600MG N22052 001 May 30, 2007 May NEWA
ZOLPIDEM TARTRATE
TABLET; ORAL
ZOLPIDEM TARTRATE
>A> AB WOCKHARDT 5MG N78426 001 May 15, 2007 May NEWA
>A> AB 10MG N78426 002 May 15, 2007 May NEWA
ADDITIONS/DELETIONS FOR OTC DRUG PRODUCT LIST BROMPHENIRAMINE MALEATE; PSEUDOEPHEDRINE HYDROCHLORIDE
TABLET, EXTENDED RELEASE; ORAL
EFIDAC 24 PSEUDOEPHEDRINE HYDROCHLORIDE/BROMPHENIRAMINE MALEATE
>D> + ALZA 16MG;240MG N19672 001 Mar 29, 1996 May DISC
>A> @ 16MG;240MG N19672 001 Mar 29, 1996 May DISC
NICOTINE POLACRILEX
GUM, CHEWING; BUCCAL
NICOTINE POLACRILEX
>A> PERRIGO R AND D EQ 2MG BASE N78547 001 May 24, 2007 May NEWA
>A> EQ 4MG BASE N78546 001 May 24, 2007 May NEWA
PSEUDOEPHEDRINE HYDROCHLORIDE
TABLET, EXTENDED RELEASE; ORAL
>D> EFIDAC 24 PSEUDOEPHEDRINE HYDROCHLORIDE
>D> + ALZA 240MG N20021 002 Dec 15, 1992 May CTNA
>A> SUDAFED 24 HOUR
>A> + ALZA 240MG N20021 002 Dec 15, 1992 May CTNA
Date created: June 6, 2007; updated August 8, 2007 |
|
|
||||||
 | ||||||
|
||||||